We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




False-Positive Mammography Findings May Increase Breast Cancer Risk

By HospiMedica International staff writers
Posted on 26 Apr 2012
False-positive mammograms could be an indicator of underlying pathology that could result in breast cancer, according to recent findings. More...


The study’s findings were published April 10, 2012, in the Journal of the National Cancer Institute. Screening mammography is associated with false-positive test results in disease-free women, and those women are typically referred back for routine screening after the initial diagnostic work-up does not reveal cancer. Suspicious findings on screenings leading to false-positives include asymmetric densities, skin thickening or retraction, tumor-like masses, recently retracted nipples or suspicious axillary lymph nodes. It is unknown if women whose mammographic screenings show these results have a higher long-term risk for breast cancer compared to women who at first test negative.

In order to determine if women who test false-positive after mammography screenings have a higher risk of developing breast cancer than those who test negative, My von Euler-Chelpin, PhD, in the department of public health at the University of Copenhagen (Denmark) and colleagues, gathered data from a long-standing population-based screening mammography program in Copenhagen, Denmark, from 1991-2005. They evaluated the risk of breast cancer and ductal carcinoma in situ in women who had received false-positive test results between the ages of 50-69. The age-adjusted relative risk of breast cancer for women who had tested false positive for breast cancer was compared to women who had tested negative.

The researchers found that women who had tested negative for breast cancer had an absolute cancer rate of 339/100,000 person-years at risk, compared to women who tested false positive, who had an absolute cancer rate of 583/100,000 person-years at risk. The relative risk of breast cancer in women with false-positive tests was statistically significantly higher than women who tested negative even at six or more years after the test. However, the researchers cautioned, “the excess breast cancer risk in women with false-positive tests may be attributable to misclassification of malignancies already present at the baseline assessment,” the authors wrote. Thus, new screening techniques such as high-resolution ultrasound and stereotactic biopsy may result in more effective diagnoses and fewer false positives on first screen.

The authors also cautioned that the experience of a false positive may cause anxiety, which may discourage women from attending regular screenings. However, the long-term excess risk of breast cancer in women who tested false positive underscores the need for women to have regular screenings. “Based on the findings in this study, it may be beneficial to actively encourage women with false-positive tests to continue to attend regular screening.”

Related Links:

University of Copenhagen




Gold Member
Neonatal Heel Incision Device
Tenderfoot
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Pediatric Mask
Respire SOFT
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image Credit: iStock

Updated Head Injury Guidelines Support Risk-Based CT and Observation Decisions

Head injuries are a common reason for emergency department visits, with most cases classified as mild. However, clinicians must identify patients at risk of intracranial bleeding or other serious injuries... Read more

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Point of Care

view channel
Image: Jessica Ramella-Roman, professor of biomedical engineering at Florida International University, holding the PPRIM (Portable Preterm Imaging) device designed to detect early signs of preterm labor risk. (Photo courtesy of Florida International University)

Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier

Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.